The agreement between the GWT and the Medicine Department of TU happened to know more about the causes of diabetes and the relation between excessive glucose in blood, the hallmark of diabetes, and adverse affects of diabetes disease to many organ functions.The collaboration between Boehringer Ingelheim, GWT and the TU Dresden, they work together to improve the knowledge of the diabetes and that ultimately leads to the invention of better treatment ways to treat this diabetes more effectively. Boehringer Ingelheim is strengthened in translating all the basic scientific findings in an effective way as it has five years of industrial experience.
The scientific research results of the diabetes disease can help in further studies to formulate new medicines in clinical testing, or these it can also used to understand better in how drug individuals are tested with the help if biomarkers. All the research studies together can be used to show the clinical benefits to the patients.
The GWT-TUD is a firm of the TUDAG-Group, the Technische Universität Dresden. This is actually a service provider for knowledge and technologies transactions and sets up solutions for definite projects and queries elevated in R&D for employers in the industry.
No comments:
Post a Comment